TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PYXS

Pyxis Oncology Inc

Healthcare · Biotechnology

3.40$ +5.2% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PYXS
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
99.5% 79.8% 99.5% 88.3% 71.7% 84.3% 78.8%
99.4% 79.6% 98.1% 84.8% 5.6% 12.4% 16.9%
99.4% 79.6% 98.1% 84.8% 68.7% 80.8% 73.1%
0.3% 0.0% 0.8%
0.4%
0.4% 19.1% 0.4% 5.3%
14.0% 1.7%
114.5% 254.1% 6.7% 23.9% 27.6% 23.2% 41.6%
3.7% 36.3% 6.7% 15.0% 14.8% 11.2% 23.1%
0.0% 6.1% 0.1% 0.7% 0.9% 1.8%
2.5% 10.6% 4.3% 3.4% 2.2% 3.1% 11.9%
-14.5% -154.1% 93.3% 76.1% 72.4% 76.8% 58.4%
-14.7% -155.1% -32.8% -100.5% -164.8% -231.3% -484.2%
173.2% 338.0% 11.5% 15.6% 23.0% 37.2% 67.9%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?